| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/07/2006 | CA2026147C Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 02/02/2006 | WO2006012627A2 Actrii receptor polypeptides, methods and compositions |
| 02/02/2006 | WO2006012476A2 Method for treating nervous system disorders and conditions |
| 02/02/2006 | WO2006012474A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | WO2006012256A2 Fkbp binding composition and pharmaceutical use thereof |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | WO2006010620A2 Olanzapine salts and their conversion to olanzapine free base |
| 02/02/2006 | WO2006010591A2 Quinazoline derivatives |
| 02/02/2006 | WO2006010587A1 Use of compounds active on the sigma receptor for the treatment of mechanical allodynia |
| 02/02/2006 | WO2006010577A1 Substituted 3-phenylpiperidine derivatives |
| 02/02/2006 | WO2006010362A1 Amino adamantane derivatives, methods for the production and use thereof |
| 02/02/2006 | WO2005112903A3 Use of ghrelin antagonists for improving cognition and memory |
| 02/02/2006 | WO2005056056A3 The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
| 02/02/2006 | WO2004002507A8 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025473 Pharmaceutical formulations containing substituted 2 heteroarylaminoacetic acid compounds |
| 02/02/2006 | US20060025471 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
| 02/02/2006 | US20060025469 Methods for decreasing beta amyloid protein |
| 02/02/2006 | US20060025464 Benzimidazole derivatives as therapeutic agents |
| 02/02/2006 | US20060025461 Triazole derivative |
| 02/02/2006 | US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits |
| 02/02/2006 | US20060025456 Serotonin reuptake inhibitors; dimethyl-(2-pyridin-3-yl-cyclohex-1-enylmethyl)-amine and the corresponding dihydrochloride; analgesics, anxiety disorders; side effects reduction |
| 02/02/2006 | US20060025452 Method of treating demyelinating diseases or conditions |
| 02/02/2006 | US20060025443 3(3-methoxyphenyl)-3-(3-dimethylaminopropyl)-4,4-dimethylpiperidine-2,6-dione pamoate; serotonin receptor antagonist; antidepressant, anxiolytic agent; migraine and sleep apnoea; weight loss and hepatocyte changes |
| 02/02/2006 | US20060025435 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 02/02/2006 | US20060025434 Therapeutic agents for drug/substance dependence |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025431 E.g., 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; treating non-insulin dependent diabetes |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025422 Remedy for integration dysfunction syndrome |
| 02/02/2006 | US20060025418 Methods of making and using N-desmethylzopiclone |
| 02/02/2006 | US20060025417 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025407 Succinoylaminobenzodiazepines as inhibitors of Abeta protein production |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025402 Benzimidazolidinone derivatives as muscarinic agents |
| 02/02/2006 | US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/02/2006 | US20060025334 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024759 Complex of a chaperone with beta-amyloid and methods employing this complex |
| 02/02/2006 | US20060024334 Immunotherapeutic methods and systems |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | DE102004034623A1 Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 6-formyl-tetrahydropteridines, processes for their preparation and their use as medicaments |
| 02/02/2006 | DE102004033818A1 Pharmaceutical active agent, useful to treat multiple sclerosis and strengthen the immune system and as antimicrobial agents, comprises mouth secretion of wall lizards or green lizards, Baypamune and tarantula D4 |
| 02/02/2006 | CA2575341A1 Trpv1 agonists, formulations containing them and uses thereof |
| 02/02/2006 | CA2575272A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 02/02/2006 | CA2575214A1 Substituted triazines as prion protein ligands and their use to detect or remove prions |
| 02/02/2006 | CA2574685A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | CA2574420A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | CA2574315A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | CA2574310A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | CA2574169A1 New heterocyclic carboxylic acid amide derivatives |
| 02/02/2006 | CA2574167A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 02/02/2006 | CA2574158A1 New benzoyl urea derivatives |
| 02/02/2006 | CA2574155A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
| 02/02/2006 | CA2574148A1 4-benzylidene-piperidine derivatives |
| 02/02/2006 | CA2573122A1 Use of compounds active on the sigma receptor for the treatment of mechanical allodynia |
| 02/02/2006 | CA2571926A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 02/02/2006 | CA2571223A1 Quinazoline derivatives |
| 02/01/2006 | EP1621212A1 Formulations comprising antisense nucleotides to connexins |
| 02/01/2006 | EP1621208A1 DNA vaccination for treatment of autoimmune disease |
| 02/01/2006 | EP1621202A1 Freeze-dried preparation containing methylcobalamin and process for producing the same |
| 02/01/2006 | EP1621201A1 Hesperidin for prophylaxis and treatment of diseases of the central nervous system, in particular Alzheimer's and Parkinson's diseases, for therapy after stroke as well as for chronic pain. |
| 02/01/2006 | EP1621199A1 Remedies for diseases to be applied to eye |
| 02/01/2006 | EP1621198A2 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
| 02/01/2006 | EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 02/01/2006 | EP1621190A1 Deprenyl compounds for treating Multiple Sclerosis |
| 02/01/2006 | EP1621189A2 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function |
| 02/01/2006 | EP1620441A1 Thiadiazine derivatives and use thereof as positive ampa receptor modulators |
| 02/01/2006 | EP1620439A1 New polymorphs of olanzapine hydrochloride |
| 02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/01/2006 | EP1620428A1 Substituted pyrimidinones and pyrimidinthiones as crf antagonists |
| 02/01/2006 | EP1620410A1 Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 02/01/2006 | EP1620409A1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 02/01/2006 | EP1620399A1 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 02/01/2006 | EP1620182A1 Methods for treating sinus headache |
| 02/01/2006 | EP1620103A1 Combinations comprising anti-epileptic drugs for the treatment of neurological disorders |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1620084A1 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract |
| 02/01/2006 | EP1620058A2 Composition for improving cognition and memory |
| 02/01/2006 | EP1619948A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands |
| 02/01/2006 | EP1500654B1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 02/01/2006 | EP1430144A4 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 02/01/2006 | EP1425281B1 Tricyclic CRF receptor antagonists |
| 02/01/2006 | EP1334082A4 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| 02/01/2006 | EP1268502B1 O-aryl glucoside sglt2 inhibitors and method |
| 02/01/2006 | EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 02/01/2006 | EP1129204B1 Novel system for regulating transgene expression |
| 02/01/2006 | EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | EP0956040B1 Stimulation of host defense mechanisms against viral challenges |